Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VEGFR-2-IN-18 (Compound 15d) is a high-potency inhibitor of VEGFR-2, with an IC 50 value of 60 nM. This compound effectively initiates cell apoptosis and demonstrates significant antitumor properties [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | VEGFR-2-IN-18 (Compound 15d) is a high-potency inhibitor of VEGFR-2, with an IC 50 value of 60 nM. This compound effectively initiates cell apoptosis and demonstrates significant antitumor properties [1]. |
In vitro | VEGFR-2-IN-18 (Compound 15d) demonstrates antiproliferative efficacy, as evidenced by IC 50 values of 24.10 ± 2.12 μM for HepG2 cells, 40.90 ± 3.46 μM for PC3 cells, 33.40 ± 2.92 μM for MCF-7 cells, and 221.25 ± 2.55 μM against WI-38 cells [1]. |
Molecular Weight | 376.8 |
Formula | C20H13ClN4O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VEGFR-2-IN-18 inhibitor inhibit